CannTrust Holdings Inc. will begin trading on the New York Stock Exchange today (February 25).
CannTrust’s shares will trade on the NYSE under the ticker symbol “CTST”. The Company’s common shares will continue to be listed on the Toronto Stock Exchange under the ticker symbol “TRST”.
Shareholders that purchased common shares on the OTC Markets Pink Open Market may now trade their shares on the NYSE.
“We are a fast-growing company that is continuously looking to increase our international presence,” said Peter Aceto, Chief Executive Officer.
“The NYSE listing is another significant milestone in the evolution of CannTrust and we are excited to share more about our planned growth initiatives in the near future.”
CannTrust is a federally regulated licensed producer of medical and recreational cannabis in Canada.
Founded by pharmacists, CannTrust brings more than 40 years of pharmaceutical and healthcare experience to the medical cannabis industry and serves more than 63,000 medical patients with its dried, extract and capsule products. The Company operates its 450,000 sq. ft. Niagara Perpetual Harvest Facility in Pelham, Ontario, has been permitted to construct another 390,000 sq. ft. facility in Pelham, and prepares and packages its product portfolio at its 60,000 sq. ft. manufacturing centre of excellence in Vaughan, Ontario.Cannabis Business Worldwide